EXTON, PA--(Marketwire - March 15, 2013) - West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board has approved the payment of a second-quarter 2013 cash dividend of $0.19 per share. The dividend will be paid on May 1, 2013 to shareholders of record on April 17, 2013.
West works side-by-side with its healthcare partners from concept to the patient, designing and manufacturing packaging, diagnostic and delivery systems that promote the efficiency, reliability and safety of their products. Every day, West is leading the way with cutting-edge technologies and quality systems, a thorough understanding of global regulatory compliance, and an unmatched and growing knowledge base of relevant pharmaceutical product testing, development and packaging. Based in Exton, Pa., West supports its customers from sales, manufacturing, customer support and research and development locations in North and South America, Europe, Asia and Australia. Established in 1923, West's 2012 sales were $1.3 billion.